TTK Healthcare Limited (NSE:TTKHLTCARE)
898.95
+10.40 (1.17%)
May 22, 2026, 3:30 PM IST
TTK Healthcare Revenue
TTK Healthcare had revenue of 2.09B INR in the quarter ending December 31, 2025, with 2.22% growth. This brings the company's revenue in the last twelve months to 8.30B, up 4.73% year-over-year. In the fiscal year ending March 31, 2025, TTK Healthcare had annual revenue of 8.01B with 6.47% growth.
Revenue (ttm)
8.30B
Revenue Growth
+4.73%
P/S Ratio
1.52
Revenue / Employee
6.20M
Employees
1,339
Market Cap
12.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 8.01B | 487.00M | 6.47% |
| Mar 31, 2024 | 7.53B | 276.84M | 3.82% |
| Mar 31, 2023 | 7.25B | 1.26B | 21.01% |
| Mar 31, 2022 | 5.99B | 1.23B | 25.88% |
| Mar 31, 2021 | 4.76B | -1.70B | -26.28% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 277.12B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 103.14B |
| Ind-Swift Laboratories | 5.94B |
| GPT Healthcare | 4.78B |
| Tarsons Products | 4.47B |
| Beta Drugs | 3.96B |